QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...

The company also highlighted advancements in digital PCR with the QIAcuity Diagnostic platform, expanding its applications in oncology and infectious diseases. CFO Roland Sackers noted an adjusted ...